Slovenian pharmaceutical group Krka upped sales by 23% year-on-year in Romania in the first nine months, to EUR 40.2 million. The increase was mainly driven by prescription drugs, according to a report of the company, cited by local Wall-street.ro.

Krka registered sales of EUR 32.8 million in Romania in January-September 2013.

The company’s most sold products were the drugs given based on medical prescription, mainly Atoris, Roswera, Prenessa and Co-Prenessa, Tolura, Karbis, Enap and Nolpaza.

Irina Popescu, irina.popescu@romania-insider.com